UNASYN 0.75 G.
Country: Iżrael
Lingwa: Ingliż
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
AMPICILLIN AS SODIUM 500 MG; SULBACTAM AS SODIUM 250 MG
Disponibbli minn:
PFIZER PHARMACEUTICALS ISRAEL LTD
Kodiċi ATC:
J01CR01
Għamla farmaċewtika:
POWDER FOR SOLUTION FOR INJECTION
Rotta amministrattiva:
I.M, I.V
Manifatturat minn:
HAUPT PHARMA LATINA S.R.L, ITALY
Grupp terapewtiku:
AMPICILLIN AND ENZYME INHIBITOR
Indikazzjonijiet terapewtiċi:
Sulbactam sodium/ampicillin sodium IM/IV is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) Skin and Skin Structure Infections. 2) Intra-Abdominal Infections. 3) Gynecological Infections.
Data ta 'l-awtorizzazzjoni:
2011-05-01
